What MS Downturn? Bruker is Latest to Launch New Instrument with ultrafleXtreme MALDI-TOF/TOF

The anticipated weak mass-spec market has not stopped vendors from launching new instruments, which may pay off later in the year when spending from the economic stimulus package could hit instrument manufacturers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.